Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
3911 ARTÍCULOS , VIENDO DEL 2491 AL 2505
Potential Use of Calpain Inhibitors as Brain Injury Therapy
Cagmat EB, Guingab-Cagmat JD, Vakulenko AV, Hayes RL, Anagli J.
In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 40.
Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA, Scahill RI, Wetzel R, Wild EJ, Tabrizi SJ.
Nat Rev Dis Primers. 2015 Apr 23;1:15005. doi: 10.1038/nrdp.2015.5.
Nat Rev Dis Primers. 2015 Apr 23;1:15052. doi: 10.1038/nrdp.2015.52.
How to make striatal projection neurons
Fjodorova M, Noakes Z, Li M.
Neurogenesis (Austin). 2015 Dec 15;2(1):e1100227. doi: 10.1080/23262133.2015.1100227. eCollection 2015.
Neurodegenerative Diseases: Where Are We Not Looking for Answers?
Koroshetz WJ, Mucke L.
In: Nikolich K, Hyman SE, editors. Translational Neuroscience: Toward New Therapies [Internet]. Cambridge (MA): MIT Press; 2015. Chapter 5.
Preclinical and Clinical Understanding: Major Gaps in Our Understanding and Capabilities
Koo EH.
In: Nikolich K, Hyman SE, editors. Translational Neuroscience: Toward New Therapies [Internet]. Cambridge (MA): MIT Press; 2015. Chapter 6.
Biparietal variant of Alzheimer's disease: a rare presentation of a common disease
Marques IB, Tábuas-Pereira M, Milheiro M, Santana I.
BMJ Case Rep. 2015 Jan 5;2015:bcr2014207011. doi: 10.1136/bcr-2014-207011.
Forkhead box G1 gene haploinsufficiency: an emerging cause of dyskinetic encephalopathy of infancy
Bertossi C, Cassina M, Cappellari A, Toldo I, Nosadini M, Rigon C, Suppiej A, Sartori S.
Neuropediatrics. 2015 Feb;46(1):56-64. doi: 10.1055/s-0034-1395345. Epub 2015 Jan 7.
Triheptanoin improves brain energy metabolism in patients with Huntington disease
Adanyeguh IM, Rinaldi D, Henry PG, Caillet S, Valabregue R, Durr A, Mochel F.
Neurology. 2015 Feb 3;84(5):490-5. doi: 10.1212/WNL.0000000000001214. Epub 2015 Jan 7.
The human histaminergic system in neuropsychiatric disorders
Shan L, Bao AM, Swaab DF.
Trends Neurosci. 2015 Mar;38(3):167-77. doi: 10.1016/j.tins.2014.12.008. Epub 2015 Jan 7.
DNA triplet repeat expansion and mismatch repair
Iyer RR, Pluciennik A, Napierala M, Wells RD.
Annu Rev Biochem. 2015;84:199-226. doi: 10.1146/annurev-biochem-060614-034010. Epub 2015 Jan 2.
Flavonoid-based therapies in the early management of neurodegenerative diseases
Solanki I, Parihar P, Mansuri ML, Parihar MS.
Adv Nutr. 2015 Jan 15;6(1):64-72. doi: 10.3945/an.114.007500. Print 2015 Jan.
The impairment of cholesterol metabolism in Huntington disease
Leoni V, Caccia C.
Biochim Biophys Acta. 2015 Aug;1851(8):1095-105. doi: 10.1016/j.bbalip.2014.12.018. Epub 2015 Jan 14.
Rasagiline for the treatment of parkinsonism in Huntington's disease
Pérez-Pérez J, Martínez-Horta S, Pagonabarraga J, Carceller M, Kulisevsky J.
Parkinsonism Relat Disord. 2015 Mar;21(3):340-2. doi: 10.1016/j.parkreldis.2015.01.002. Epub 2015 Jan 10.
Repeat instability during DNA repair: Insights from model systems
Usdin K, House NC, Freudenreich CH.
Crit Rev Biochem Mol Biol. 2015 Mar-Apr;50(2):142-67. doi: 10.3109/10409238.2014.999192. Epub 2015 Jan 22.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.